Cohesion's CoStasis Surgical Hemostat To Ship In July, Gains FDA Approval
This article was originally published in The Gray Sheet
Executive Summary
Tyco International's U.S. Surgical unit will market Cohesion Technologies' CoStasis liquid surgical hemostat. Shipments are expected to begin in early July.
You may also be interested in...
Fusion Shipping FloSeal Hemostatic Sealant Following Dec. 8 FDA Approval
Fusion Medical Technologies commenced shipments of its FloSeal hemostatic sealant on Dec. 9 at a price of $125 for a 4 ml kit, following FDA approval Dec. 8.
CoStasis Stops Bleeding At Hard And Soft Tissue Sites - Cohesion PMA Study
Cohesion Technologies plans to file a premarket approval application this spring for its CoStasis surgical hemostat for treatment of bleeding in cardiovascular, hepatic, general and orthopedic surgery procedures, the firm announced Jan. 14.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.